Chongqing Zhifei Biological Products Co Ltd

CN

Health Care

40.21 ₽

Current price

Strong buy
40.21 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    29 / 1361

  • Position in country

    910 / 7387

  • Return on Assets, %

    19.7

    -40.3

  • Net income margin, %

    17.4

    -180

  • EBITDA margin, %

    20.9

    -168.2

  • Debt to Equity, %

    14.4

    3.2

  • Intangible assets and goodwill, %

    2.4

    0.2

  • Revenue CAGR 3Y, %

    53.4

    12.5

  • Total Equity change 1Y, %

    16.8

    -9

  • Revenue Y, % chg

    23.7

    0

  • P/E

    11.6

    31

  • P/BV

    3.2

    1.8

  • P/S

    1.9

    10.3

  • EV/S

    2

    7.5

  • EV/EBITDA

    10

    -1.6

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    60.2

    131.1

  • Forward P/E

    8.5

    21.4

  • Dividend Yield, %

    0.8

    1.1

  • Forward Dividend Yield, %

    0.3

    0.1

  • Expected dividend per share

    0.1

    0

  • Payout Ratio, %

    9.9

    0

  • Dividend Ex Date

    2023-06-16

Get an analytical review of this company

Competitors

Ranks

  • Imeik Technology Development Co Ltd

    00%

  • Chongqing Zhifei Biological Products Co Ltd

    00%

  • Shanghai RAAS Blood Products Co Ltd

    00%

  • Hualan Biological Engineering Inc

    00%

  • Beijing Tiantan Biological Products Corp Ltd

    00%

  • Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

    00%

  • Akeso Inc

    00%

  • Gan & Lee Pharmaceuticals

    00%

  • Innovent Biologics Inc

    00%

  • Beijing Wantai Biological Pharmacy Enterprise Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Biotechnology

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    13576.3

  • Ticker

    300122.SZ

  • ISIN

    CNE100000V20

  • IPO date

    2010-09-28

  • Availability on Russian exchanges

    No

  • Reporting for

    2023-08-28

  • Date fact. publication of reports

    2023-06-30

Company Description

Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus and other virus, general drugs and other biological products, among others. The Company is also involved in the agency sale of vaccines. The Company distributes its products in domestic market and to overseas markets, with Central China as its main market.